Knowledge and attitudes towards hepatitis C and injecting drug use among mental-health support workers of a community managed organisation
Grenville Rose A , Elena Cama B C , Loren Brener B and Carla Treloar BA Aftercare, Rozelle Hospital, Church Street, Lilyfield, NSW 2040, Australia. Email: grenville.rose@aftercare.com.au
B Centre for Social Research in Health, University of New South Wales, University of New South Wales, Sydney, NSW 2052, Australia. Email: l.brener@unsw.edu.au, c.treloar@unsw.edu.au
C Corresponding author. Email: e.cama@unsw.edu.au
Australian Health Review 37(5) 654-659 https://doi.org/10.1071/AH13134
Submitted: 4 July 2013 Accepted: 21 August 2013 Published: 28 October 2013
Abstract
Objectives People with mental illness are at significantly higher risk of acquiring hepatitis C virus (HCV) compared with the general population. This study assessed knowledge of and attitudes towards people with HCV and people who inject drugs (PWID) among support workers of clients with mental illness.
Methods Support workers from a community managed organisation (CMO) in Australia were recruited to complete an online cross-sectional survey. The survey collected data about their knowledge of HCV and attitudes towards PWID and people with HCV.
Results Valid responses were received from 117 support workers. Although HCV knowledge was moderate, there were significant knowledge gaps around transmission and treatment of HCV. Higher HCV knowledge was significantly associated with more positive attitudes towards PWID, but not with attitudes towards people with HCV. Participants had more positive attitudes towards people with HCV than towards PWID. Additionally, those with more positive attitudes towards HCV tended to also have more positive attitudes towards PWID.
Conclusions Given that people with mental illness are at higher risk of acquiring HCV, these results point to the need for education targeted at support workers of clients with mental illness to increase HCV knowledge and promote positive attitudes towards PWID and people with HCV.
What is known about this topic? The limited research available suggests that there are gaps in HCV knowledge among mental-health-service providers, although such research has generally targeted physicians.
What does this paper add? This paper is the first to assess HCV knowledge, attitudes towards PWID and HCV among mental-health support workers. The findings suggest that although HCV knowledge is moderate, significant gaps exist, which are related to negative attitudes towards PWID.
What are the implications for practitioners? Supportive and non-judgemental care is essential for people with mental illness and HCV, due to the potential for a double stigma arising from negative attitudes towards both mental illness and injecting drug use. This paper highlights the importance of targeted education for workers in the mental-health sector, to increase HCV knowledge and promote positive attitudes towards people with co-occurring mental-health, substance use problems and HCV.
Additional keywords: community-based care, comorbidity, mental illness, stigma.
References
[1] Gunewardene R, Lampe L, Ilchef R. Prevalence of hepatitis C in two inpatient psychiatry populations. Australas Psychiatry 2010; 18 330–4.| Prevalence of hepatitis C in two inpatient psychiatry populations.Crossref | GoogleScholarGoogle Scholar | 20645899PubMed |
[2] Lacey C, Ellen S, Devlin H, Wright E, Mijch A. Hepatitis C in psychiatry inpatients: testing rates, prevalence and risk behaviours. Australas Psychiatry 2007; 15 315–9.
| Hepatitis C in psychiatry inpatients: testing rates, prevalence and risk behaviours.Crossref | GoogleScholarGoogle Scholar | 17612885PubMed |
[3] Global Burden of Hepatitis C Working Group Global Burden of Disease (GBD) for hepatitis C. J Clin Pharmacol 2004; 44 20–9.
| Global Burden of Disease (GBD) for hepatitis C.Crossref | GoogleScholarGoogle Scholar | 14681338PubMed |
[4] Davidson S, Judd F, Jolley D, Hocking B, Thompson S, Hyland B. Risk factors for HIV/AIDS and hepatitis C among the chronic mentally ill. Aust N Z J Psychiatry 2001; 35 203–9.
| Risk factors for HIV/AIDS and hepatitis C among the chronic mentally ill.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3Mvnt1yltA%3D%3D&md5=8d62898dd3068f0c9a12241b0abb3415CAS | 11284902PubMed |
[5] Himelhoch S, Goldberg R, Calmes C, Medoff D, Slade E, Dixon L, Gallucci G, Rosenberg S. Screening for and prevalence of HIV and hepatitis C among an outpatient urban sample of people with serious mental illness and co-occurring substance abuse. J Community Psychol 2011; 39 231–9.
| Screening for and prevalence of HIV and hepatitis C among an outpatient urban sample of people with serious mental illness and co-occurring substance abuse.Crossref | GoogleScholarGoogle Scholar | 23543939PubMed |
[6] d’Souza RFC, Glynn MJ, Alstead E, Osonayo C, Foster GR. Knowledge of chronic hepatitis C among East London primary care physicians following the Department of Health’s educational campaign. QJM 2004; 97 331–6.
| Knowledge of chronic hepatitis C among East London primary care physicians following the Department of Health’s educational campaign.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2c3ltlGhtw%3D%3D&md5=ad161d61ecc6ab91a86b63a8ab302751CAS |
[7] Dev A, Sievert W. A survey of Australian general practice management of hepatitis C-infected patients from non-English-speaking backgrounds. J Gastroenterol Hepatol 2002; 17 295–300.
| A survey of Australian general practice management of hepatitis C-infected patients from non-English-speaking backgrounds.Crossref | GoogleScholarGoogle Scholar | 11982700PubMed |
[8] Lagios L, Deane F. Psychiatrists’ knowledge and practices in screening and assessment of hepatitis C for inpatients with severe mental illness. Australas Psychiatry 2011; 19 156–9.
| Psychiatrists’ knowledge and practices in screening and assessment of hepatitis C for inpatients with severe mental illness.Crossref | GoogleScholarGoogle Scholar |
[9] Shehab TM, Sonnad SS, Lok AS. Management of hepatitis C patients by primary care physicians in the USA: Results of a national survey. J Viral Hepat 2001; 8 377–83.
| Management of hepatitis C patients by primary care physicians in the USA: Results of a national survey.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3MrgslSlsg%3D%3D&md5=a40a4761e49f6a8e065769a607675804CAS | 11555196PubMed |
[10] Zickmund SL, Brown KE, Bielefeldt K. A systematic review of provider knowledge of hepatitis C: is it enough for a complex disease? Dig Dis Sci 2007; 52 2550–6.
| A systematic review of provider knowledge of hepatitis C: is it enough for a complex disease?Crossref | GoogleScholarGoogle Scholar | 17406823PubMed |
[11] Goldberg RW, Tapscott SL, Calmes CA, Wolfe RS. HIV and hepatitis C knowledge among individuals with serious mental illness. Psychiatr Rehabil J 2009; 33 47–9.
| HIV and hepatitis C knowledge among individuals with serious mental illness.Crossref | GoogleScholarGoogle Scholar | 19592379PubMed |
[12] Brener L, Treloar C. Alcohol and other drug treatment experiences of hepatitis C-positive and negative clients: Implications for hepatitis C treatment. Aust Health Rev 2009; 33 100–6.
| Alcohol and other drug treatment experiences of hepatitis C-positive and negative clients: Implications for hepatitis C treatment.Crossref | GoogleScholarGoogle Scholar | 19203339PubMed |
[13] Day C, Ross J, Dolan K. Hepatitis C-related discrimination among heroin users in Sydney: Drug user or hepatitis C discrimination? Drug Alcohol Rev 2003; 22 317–21.
| Hepatitis C-related discrimination among heroin users in Sydney: Drug user or hepatitis C discrimination?Crossref | GoogleScholarGoogle Scholar | 15385226PubMed |
[14] Tindal C, Cook K, Foster N. Theorising stigma and the experiences of injecting drug users in Australia. Aust J Primary Health 2010; 16 119–125.
| Theorising stigma and the experiences of injecting drug users in Australia.Crossref | GoogleScholarGoogle Scholar |
[15] Butt G. Stigma in the context of hepatitis C: concept analysis. J Adv Nurs 2008; 62 712–24.
| Stigma in the context of hepatitis C: concept analysis.Crossref | GoogleScholarGoogle Scholar | 18503656PubMed |
[16] Treloar C, Hopwood M. Infection control in the context of hepatitis C disclosure: implications for education of healthcare professionals. Educ Health 2004; 17 183–91.
| Infection control in the context of hepatitis C disclosure: implications for education of healthcare professionals.Crossref | GoogleScholarGoogle Scholar |
[17] Butt G, Paterson BL, McGuinness LK. Living with the stigma of hepatitis C. West J Nurs Res 2008; 30 204–21.
| Living with the stigma of hepatitis C.Crossref | GoogleScholarGoogle Scholar | 17630381PubMed |
[18] Earnshaw VA, Quinn DM. The impact of stigma in healthcare on people living with chronic illnesses. J Health Psychol 2012; 17 157–68.
| The impact of stigma in healthcare on people living with chronic illnesses.Crossref | GoogleScholarGoogle Scholar | 21799078PubMed |
[19] Hopwood M, Treloar C, Bryant J. Hepatitis C and injecting-related discrimination in New South Wales, Australia. Drugs Educ Prev Policy 2006; 13 61–75.
| Hepatitis C and injecting-related discrimination in New South Wales, Australia.Crossref | GoogleScholarGoogle Scholar |
[20] Fraser S, Treloar C. ‘Spoiled identity’ in hepatitis C infection: the binary logic of despair. Crit Public Health 2006; 16 99–110.
| ‘Spoiled identity’ in hepatitis C infection: the binary logic of despair.Crossref | GoogleScholarGoogle Scholar |
[21] Hinshaw SP, Stier A. Stigma as related to mental disorders. Annu Rev Clin Psychol 2008; 4 367–93.
| Stigma as related to mental disorders.Crossref | GoogleScholarGoogle Scholar | 17716044PubMed |
[22] Lauber C, Nordt C, Braunschweig C, Rössler W. Do mental-health professional stigmatize their patients? Acta Psychiatr Scand 2006; 113 51–9.
| Do mental-health professional stigmatize their patients?Crossref | GoogleScholarGoogle Scholar |
[23] Department of Health & Ageing. National mental-health report 2010: summary of 15 years of reform in Australia’s mental-health services under the National Mental Health Strategy 1993–2008. Canberra: Commonwealth of Australia; 2010.
[24] Balfour L, Kowal J, Corace KM, Tasca GA, Krysanski V, Cooper CL, Garber G. Increasing public awareness about hepatitis C: development and validation of the brief hepatitis C knowledge scale. Scand J Caring Sci 2009; 23 801–8.
| Increasing public awareness about hepatitis C: development and validation of the brief hepatitis C knowledge scale.Crossref | GoogleScholarGoogle Scholar | 19500309PubMed |
[25] Horwitz R, Brener L, Treloar C. Evaluation of an integrated care service facility for people living with hepatitis C in New Zealand. Int J Integr Care 2012; 12 1–9.
[26] Brener L, von Hippel B. Measuring attitudes toward injecting drug users and people with hepatitis C. Subst Use Misuse 2008; 43 295–302.
| Measuring attitudes toward injecting drug users and people with hepatitis C.Crossref | GoogleScholarGoogle Scholar | 18365932PubMed |
[27] Ahern J, Stuber J, Galea S. Stigma, discrimination and the health and illicit drug users. Drug Alc Dep 2007; 88 188–96.
| Stigma, discrimination and the health and illicit drug users.Crossref | GoogleScholarGoogle Scholar |
[28] Finn M, Sarangi S. Humanizing HIV/AIDS and its (re)stigmatizing effects: HIV public ‘positive’ speaking in India. Health (London) 2009; 13 47–65.
| 19103715PubMed |
[29] Paxton S. The impact of utilizing HIV-positive speakers in AIDS education. AIDS Educ Prev 2002; 14 282–94.
| The impact of utilizing HIV-positive speakers in AIDS education.Crossref | GoogleScholarGoogle Scholar | 12212715PubMed |
[30] Scollay PA, Doucett M, Perry M, Winterbottom B. AIDS education of college students: the effect of an HIV-positive lecturer. AIDS Educ Prev 1992; 4 160–71.
| 1:STN:280:DyaK38zlt1yqtA%3D%3D&md5=bd51138b66b87297ee8a9034055d74d1CAS | 1642960PubMed |
[31] Bell JS, Johns R, Rose G, Chen TF. A comparative study of consumer participation in mental-health pharmacy education. Ann Pharmacother 2006; 40 1759–65.
| A comparative study of consumer participation in mental-health pharmacy education.Crossref | GoogleScholarGoogle Scholar | 16968823PubMed |
[32] Brener L, Wilson H, Rose G, Mackenzie A, de Wit J. Challenging stereotypes and changing attitudes: Improving quality of care for people with hepatitis C through Positive Speakers programs. Psychol Health Med 2013; 18 242–9.
| Challenging stereotypes and changing attitudes: Improving quality of care for people with hepatitis C through Positive Speakers programs.Crossref | GoogleScholarGoogle Scholar | 22783938PubMed |
[33] Doyle JS, Aspinall E, Liew D, Thompson AJ, Hellard ME. Current and emerging antiviral treatments for hepatitis C infection. Br J Clin Pharmacol 2013; 75 931–43.
| Current and emerging antiviral treatments for hepatitis C infection.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3sXktFOgtrg%3D&md5=49cd61d51ab473fe1f0019734c41909fCAS | 22882367PubMed |
[34] Cohen D, Xie W, Larsen L, Marincic C, Knauss-Townsend M, Khatri A, Podsadecki T, Bernstein B. Safety of ribavirin-containing regimens of ABT-450/r, ABT-333 and ABT-267 for the treatment of HCV genotype 1 infection and efficacy in subjects with ribavirin dose reductions. Paper presented at the 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention; Kuala Lumpur, Malaysia, 30 June—3 July, 2013; 2013. Available at: http://pag.ias2013.org/Abstracts.aspx?AID=221 [verified 23 September 2013]
[35] Dore G. The changing therapeutic landscape for hepatitis C. Med J Aust 2012; 196 629–32.
| The changing therapeutic landscape for hepatitis C.Crossref | GoogleScholarGoogle Scholar | 22676877PubMed |
